Event Brief
Jan 12, 2026 at 12:07 PM ET
Health Canada Approves 1st GLP-1 Daily Pill
By The BriefBrief
The once-a-day semaglutide pill is approved for reducing heart disease and Type 2 diabetes risk.
WHO: Health Canada
WHAT: Approval of semaglutide pill
WHEN: Jan 11, 2026 at 7:00 PM ET
WHERE: Canada
WHY: To reduce the risk of heart disease and Type 2 diabetes
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
